INTRA CELLULAR THERAPIES INC's ticker is and the CUSIP is 46116X901. A total of 4 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,244,951 | +52.4% | 23,900 | +85.3% | 0.00% | – |
| Q2 2023 | $816,828 | -91.6% | 12,900 | -92.9% | 0.00% | -100.0% |
| Q1 2023 | $9,774,075 | +396.5% | 180,500 | +385.2% | 0.00% | +300.0% |
| Q4 2022 | $1,968,624 | -65.0% | 37,200 | -69.2% | 0.00% | -50.0% |
| Q3 2022 | $5,625,000 | -52.9% | 120,900 | -42.2% | 0.00% | -60.0% |
| Q2 2022 | $11,941,000 | – | 209,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 28,000 | $1,303,000 | 0.00% |
| JANE STREET GROUP, LLC | 120,900 | $5,625,000 | 0.00% |
| SIMPLEX TRADING, LLC | 20,900 | $972,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |